Genprex, Inc. (GNPX) reporting calendar
Genprex, Inc. files periodic reports with the SEC as GNPX on Nasdaq. Atlas tracks 35 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 19 Jul 2026 – 7 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 35
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open GNPX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001437749-26-016755 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001437749-26-010346 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001437749-25-035191 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0001437749-25-026965 |
| 10-Q | 31 Mar 2025 | 12 May 2025 | 42 days | 0001437749-25-016133 |
| 10-K | 31 Dec 2024 | 1 Apr 2025 | 91 days | 0001437749-25-010311 |
| 10-Q | 30 Sep 2024 | 13 Nov 2024 | 44 days | 0001437749-24-034697 |
| 10-Q | 30 Jun 2024 | 9 Aug 2024 | 40 days | 0001437749-24-025893 |
| 10-Q | 31 Mar 2024 | 15 May 2024 | 45 days | 0001437749-24-017061 |
| 10-K | 31 Dec 2023 | 1 Apr 2024 | 92 days | 0001437749-24-010426 |
| 10-Q | 30 Sep 2023 | 14 Nov 2023 | 45 days | 0001437749-23-031830 |
| 10-Q | 30 Jun 2023 | 21 Aug 2023 | 52 days | 0001437749-23-024247 |
| 10-Q | 31 Mar 2023 | 22 May 2023 | 52 days | 0001437749-23-015445 |
| 10-K | 31 Dec 2022 | 31 Mar 2023 | 90 days | 0001437749-23-008847 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001437749-22-027048 |
| 10-Q | 30 Jun 2022 | 12 Aug 2022 | 43 days | 0001437749-22-020379 |
| 10-Q | 31 Mar 2022 | 13 May 2022 | 43 days | 0001437749-22-012372 |
| 10-K | 31 Dec 2021 | 30 Mar 2022 | 89 days | 0001437749-22-007680 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001437749-21-026629 |
| 10-Q | 30 Jun 2021 | 13 Aug 2021 | 44 days | 0001437749-21-019892 |
| 10-Q | 31 Mar 2021 | 17 May 2021 | 47 days | 0001437749-21-012395 |
| 10-K | 31 Dec 2020 | 26 Mar 2021 | 85 days | 0001437749-21-007317 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001437749-20-023671 |
| 10-Q | 30 Jun 2020 | 11 Aug 2020 | 42 days | 0001437749-20-017533 |
| 10-Q | 31 Mar 2020 | 14 May 2020 | 44 days | 0001437749-20-010758 |
| 10-K | 31 Dec 2019 | 30 Mar 2020 | 90 days | 0001437749-20-006522 |
| 10-Q | 30 Sep 2019 | 14 Nov 2019 | 45 days | 0001437749-19-022847 |
| 10-Q | 30 Jun 2019 | 13 Aug 2019 | 44 days | 0001437749-19-016579 |
| 10-Q | 31 Mar 2019 | 15 May 2019 | 45 days | 0001564590-19-019363 |
| 10-K | 31 Dec 2018 | 1 Apr 2019 | 91 days | 0001564590-19-010279 |
| 10-Q | 30 Sep 2018 | 14 Nov 2018 | 45 days | 0001564590-18-029612 |
| 10-Q | 30 Jun 2018 | 14 Aug 2018 | 45 days | 0001564590-18-021749 |
| 10-Q | 31 Mar 2018 | 15 May 2018 | 45 days | 0001564590-18-013661 |
| 10-K | 31 Dec 2017 | 17 Apr 2018 | 107 days | 0001564590-18-008342 |
| 10-Q | 30 Sep 2017 | 27 Nov 2017 | 58 days | 0001185185-17-002488 |
Source: SEC EDGAR company submissions for CIK 0001595248. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.